There are 3484 resources available
POLTheta inhibitors and USP1 inhibitors for BRCA-deficient cancers
Presenter: Alan D'Andrea
Session: New targets on the horizon
Resources:
Slides
Webcast
Liquid biopsy in lymphoma
Presenter: David Kurtz
Session: Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
Resources:
Slides
Webcast
Policy and intellectual property regulatory instruments as tools to enhance access to expensive essential cancer medicines
Presenter: Elisabeth 't hoen
Session: Making essential cancer drugs affordable
Resources:
Slides
Webcast
Degrading oncogenic transcription factors
Presenter: Nicolas Thomä
Session: Protein degrading cancer drugs: The promises of the new generation
Resources:
Slides
Webcast
Degrading cancer targets on the cell surface (SureTACs)
Presenter: Madelon Maurice
Session: Protein degrading cancer drugs: The promises of the new generation
Resources:
Webcast
ER positive breast cancer: What endocrine therapy is needed in menopausal patients?
Presenter: Patrick Neven
Session: Unravelling choices for adjuvant endocrine therapy in HR+ early breast cancer
Resources:
Slides
Webcast
What is the optimal first-line treatment?
Presenter: Arnaud Scherpereel
Session: Open questions in the management of mesothelioma
Resources:
Slides
Webcast
Current systemic treatment of locally advanced colon cancer
Presenter: Jenny Seligmann
Session: Fight the enemy as soon as possible: News and views in the management of early stages colorectal cancer (CRC)
Resources:
Slides
Webcast
Innovative/novel delivery of immunotherapeutics
Presenter: Aurélien Marabelle
Session: New targets on the horizon
Resources:
Slides
Webcast
Multi-omic profiling in lymphoid neoplasms
Presenter: Iñaki Martin Subero
Session: Next generation diagnostics of blood cancer: An optimistic view on the future of cancer testing
Resources:
Slides
Webcast